PSMA4 was upregulated in invasive ductal breast carcinoma and lobular breast carcinoma in datasets from Zhao [21] and Radvanyi [20], while it was downregulated in invasive breast cancer compared with normal breast tissues in Finak's dataset [22]. Here, PSMA4 is linked to breast lobular carcinoma.